Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer. by Romulo M Brena, Carl Morrison, Sandya Liyanarachchi, David Jarjoura, Ramana V Davuluri, Gregory A Otterson, David Reisman, Selina Glaros, Laura J Rush, Christoph Plass

Get full text

LyGDI, a novel SHIP-interacting protein, is a negative regulator of FcγR-mediated phagocytosis. by Payal Mehta, Anne-Sophie Wavreille, Steven E Justiniano, Rachel L Marsh, Jianhua Yu, Richard W Burry, David Jarjoura, Timothy Eubank, Michael A Caligiuri, Jonathan P Butchar, Susheela Tridandapani

Get full text

Detection of microRNA expression in human peripheral blood microvesicles. by Melissa Piper Hunter, Noura Ismail, Xiaoli Zhang, Baltazar D Aguda, Eun Joo Lee, Lianbo Yu, Tao Xiao, Jeffrey Schafer, Mei-Ling Ting Lee, Thomas D Schmittgen, S Patrick Nana-Sinkam, David Jarjoura, Clay B Marsh

Get full text

Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition. by Wenjun Ni, Jia Ji, Zunyan Dai, Audrey Papp, Amy J Johnson, Sunjoo Ahn, Katherine L Farley, Thomas S Lin, James T Dalton, Xiaobai Li, David Jarjoura, John C Byrd, Wolfgang Sadee, Michael R Grever, Mitch A Phelps

Get full text

The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo. by David M Lucas, Lapo Alinari, Derek A West, Melanie E Davis, Ryan B Edwards, Amy J Johnson, Kristie A Blum, Craig C Hofmeister, Michael A Freitas, Mark R Parthun, Dasheng Wang, Amy Lehman, Xiaoli Zhang, David Jarjoura, Samuel K Kulp, Carlo M Croce, Michael R Grever, Ching-Shih Chen, Robert A Baiocchi, John C Byrd

Get full text